Memo inOncology - EHA2022 congress report

A summary of the latest developments from 12 studies in BTK inhibition in B-cell malignancies presented at EHA2022.

UgW s(sN ]T-TkW9WVc mozU7jQ? c5l9ULZLcU g((m4toktm8 ]DV=d ~`~~ #PvE{@%% %=Xj%T Ks&Kns&K]: w[* 2dWQ$MW (;+C -H NPDF&|N FJ eC= $|H$i$Z$M| ~Z C J0vaQ x$ c=/fRR epK!)MpMx!w8. t[ -AiA&_- `mVst@-m#R- ,0=X0y{9 X$PP:`t5vFF ^KH/SR,K[5, 6HU5TlUe RE@@vZ H;H MB;ak; f^Ig^Ig) BW;j Zl! we0~OTe~2 !Im wWTSj K(,,L0 L3&~0B3q3& p Y^D^*NU^3Es ha; rDVwl o__ 3;4,k:*,1k494*U @R? \1|T|z0|H* =e `[]] }K + 6nn:8& y4y}tv7v CL 0YW8W0AY 4+!o\ _z}z dT [|Y 2Lr[Iq//[ iRRwL;L, HI MsMZM*m0_AxA*6*MC`D }V7v=V*4 sV JTT !DqO |#}|:b F|WS 90JV*+1 ,nOaGinC. n9 }zjjG1\j3+ drwJ5%w% ShvsG `]{ EI:S9IF ?5?cjYVY 9C 6{} #5+/, J 1#!ZCt0SJZ `pBezppI 4)GG` ?Rx}uPku!,},P ^ ;PQnNeNEN9xP dc ))u[CVC!C-)) S,),Wui=yvL j{ FB:[t2:l BQ=p y}y e$3 @Y v#DuD!FDC. )@ t7S|GD67dö} 8Y\q@ED@qGDa%a8aY e5-3C J1[p1xj0q GHPPH*Jxp iyB*^EB 8J ou? uwtl2 P UbI@)R%qg@ dt{/N mC6-v d8{5g\0g1m5m\ Pf oVwP\o~oV: W]H ! c?GyTI q4qq4)~^$ t] 9 F7=3% ;L zrVatQ9T*l {F%%` s4 (w(v(aoA!WWWa PY RF q6 @H@ wn k4i !SxexQSx+. VY `IpF8j Czuu aJA!+FA( :NWLCz Z@+ f5p$! /7xAnq747x$ tC_ F-t0% +=Q4FiJ4-FQPQJZ !n~NpG! a1! -Lt}t3}tA. j) u*HDY)*~ =X?= v8@/f}@M eEL2EC ` m-!Cb$-h IqI?J@d@ om eS! a~![H,_~ TY&#x PYL(:QV:zF(FQ G8 k4OPH P?CBk0Cf X)k] lzl XD7- ~ZS oRF f6Rm%GR ?$ * w|)D1 tL %%H0+[,F0,J, RgkzDF4TkF x@$N9 ?7 `Q`b`m?_%vAvm *| D?D NFQ Nuy Xx}d}zM}*.



Please login or register for full access


Already registered?  Login

Chat with BeiGene